Microphthalmia transcription factor - Not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma
Sr. Granter et al., Microphthalmia transcription factor - Not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma, AM J DERMAT, 23(3), 2001, pp. 185-189
Microphthalmia transcription factor (Mitf), a melanocytic nuclear protein c
ritical for the embryonic development and postnatal viability of melanocyte
s, is a master lineage regulator and modulates extracellular signals. Recen
tly, Mitf expression was shown to be both a sensitive and specific marker o
f epithelioid melanoma. Because loss of specific melanocytic markers in mel
anomas with spindle cell morphology is more common compared with those tumo
rs with epithelioid morphology, we investigated the sensitivity of D5, an a
nti-Mitf antibody, for diagnosis in this diagnostically problematic subset
of melanomas. Twenty of 21 (95%) spindle cell and desmoplastic melanomas ex
amined were reactive for S-100 protein. Only 4 of 21 (19%) spindle cell and
desmoplastic melanomas were reactive for HMB-45. Six of 21 tumors (29%) we
re reactive for D5, including one case that was non-reactive for S-100 and
HMB-45. Melan-A reactivity was seen in 2 of 13 cases (15%) studied. Eight o
f 24 (33%) non-melanocytic spindle cell tumors were reactive for D5, includ
ing 4 of 6 dermatofibromas, 1 of 6 schwannomas, 1 of 2 leiomyomas, and 2 of
6 leiomyosarcomas. Although D5 was shown in a previous study to be a highl
y sensitive and specific marker for epithelioid melanomas, the results of t
his study show it is not a sensitive or specific marker of spindle cell and
desmoplastic melanomas. Nevertheless, we believe that diffuse positive sta
ining for D5 when taken in clinical, histologic and immunohistochemical con
text may be diagnostically useful in selected eases of melanoma.